ViaCyte

ViaCyte is focused on developing diabetes therapeutics.

History:

Founded in 1999 as Novocell, the name was changed to ViaCyte in 2010.

Acquisitions:
CyThera (2004)
BresaGen (US subsidiary) (2004)

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Southern California

Research Focus:
Disease Therapeutics-Research Therapeutics-Development

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: